Skip to main content
AIOBIO Co., Ltd. logo

AIOBIO Co., Ltd. — Investor Relations & Filings

Ticker · 447690 ISIN · KR7447690009 KO Manufacturing
Open in API
Filings indexed 88 across all filing types
Latest filing 2023-03-13 AGM Information
Country KR South Korea
Listing KO 447690

About AIOBIO Co., Ltd.

https://www.aiobio.com/

AIOBIO Co., Ltd. is a medical device company specializing in advanced dental care solutions. The company develops and manufactures diagnostic tools and platforms based on its proprietary Biofluorescence-Led Intelligent Screening System (BLISS) technology. Its product portfolio includes imaging devices that provide instant visual analysis for the early detection of oral health issues. AIOBIO's core offering is the LINKDENS platform, an integrated system that connects dental clinics and patients. Powered by AI-driven diagnostics, instant imaging analysis, and remote patient monitoring, LINKDENS streamlines clinical workflows, enhances diagnostic accuracy, and fosters a connected dental care experience for both professionals and patients.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by the company. It outlines the date, location, and specific agenda items (such as financial statement approval, stock option grants, and director appointments) to be voted upon at the upcoming meeting. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI), which provides shareholders with the necessary information to vote on matters at a meeting.
2023-03-13 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party allocated capital increase). It details the type of security, the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2023-03-03 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company (Aiobio) detailing a decision to issue new shares via third-party allocation (유상증자결정). This type of filing is a standard regulatory disclosure in the Korean market regarding capital changes and share issuance. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the most accurate category for announcements regarding new share issues and capital structure changes.
2023-02-16 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 100% confidence The document is a regulatory announcement regarding the acquisition of a patent ('특허권 취득') by the company AIOBIO. It provides details on the patent name, content, and utilization plan. Since this is a specific regulatory disclosure of a corporate event that does not fall into financial reporting, M&A, or governance categories, it is classified as a general regulatory filing.
2023-01-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used to disclose insider shareholdings and transactions. It specifically details the share ownership of a director (Jung Hyun-hoon) of Aiobio Co., Ltd. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions and holdings by a company executive.
2023-01-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose insider shareholdings and changes in ownership by directors or major shareholders. This corresponds to the 'Director's Dealing' category, as it details the personal share ownership and transactions of a company executive (CEO Yoon Hong-cheol).
2023-01-04 Korean

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.